Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels?

Digestive Diseases and Sciences

Volumn 50, Issue 7, 2005, Pages 1228-1231

  Kanbay, Mehmet ^a,b   Gür, Gürden ^a   Yücel, Muammer ^a   Yilmaz, Ugur ^a   Boyacioĝlu, Sedat ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

C reactive protein; Helicobacter pylori; Serum lipid levels

Indexed keywords

AMOXICILLIN; ANTIGEN; CLARITHROMYCIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEPRAZOLE; TRIACYLGLYCEROL; ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; ENZYME INHIBITOR; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BACTERIAL INFECTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ERADICATION THERAPY; FECES ANALYSIS; FEMALE; HELICOBACTER PYLORI; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; STATISTICAL SIGNIFICANCE; BLOOD; CLINICAL TRIAL; DRUG COMBINATION; HELICOBACTER INFECTION; METABOLISM; MIDDLE AGED;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OMEPRAZOLE;

EID: 23044496817     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2764-9     Document Type: Article

References (20)

1. Roussos A, Philippou N, Gourgoulianis KI: Helicobacter pylori infection and respiratory diseases: a review. W J Gastroenterol 9(1):5-8, 2003
2. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P: Association of H. pylori infection with elevated serum lipids. Atherosclerosis 142:207-210, 1999
3. Kinjo K, Sato H, Sato H, et al.: Prevalence of H. pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction. Circ J 66:805-810, 2002
4. Niemela S, Karttunen T, Korhonen T, Laara E, Karttunen R, Ikaheimo M, Kesaniemi YA: Could H. pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 75:573-575, 1996
5. Cammaroat G, Pasceri V, Gasbarrini A, Gabarrini G: Helicobacter pylori is an aetiologic factor for ischaemic heart disease: the case against. Digest Liver Dis 32:65-68, 2000
6. Realdi G, Dore P M, Fastame L: Extradigestive manifestations of H. pylori infection: Fact and fiction. Dig Dis Sci 44:229-236, 1999
7. Patel P, Gasbarrini G, Pretolani S, Gasbarrini A, Franceshi F: Extradigestive diseases and H. pylori infection. Curr Opin Gastroenterol 13:52-55, 1997
8. Ekesbo R, Nilsson PM, Lindholm LH, Persson K, Wadstrom T: Combined seropositivity for H. pylori and C. pneumonia is associated with age, obesity and social factors. J Cardiovasc Risk 7:191-195, 2000
9. Mendall MA, Goggin PM, Molineaux N, et al.: Realation of H. pylori infection and coronary heart disease. Br Heart J 71:437-439, 1994
10. Pasceri V, Cammarota G, Patti G, et al.: Association of virulent H. pylori strains with ischemic heart disease. Circulation 71:1675-1679, 1998
11. Danesh J, Youngman L, Clark S, Parish S, Peto R, Collins R: H. pylori infection and early onset myocardial infection: Case-control and sibling pairs study. BMJ 319:1157-1162, 1999
12. Strachan DP, Mendall MA, Carrington D, et al.: Relation of H. pylori infection to 13-year mortality and incident ischemic heart disease in the Caerphilly prospective heart disease study. Circulation 98:1286-1290, 1998
13. Folsom AR, Nieto FJ, Sorlie P, Chambless LE, Graham DY: H. pylori seropositivity and coronary heart disease incidence: Atherosclerosis risk in communities (ARIC) study investigators. Circulation 98:845-850, 1998
14. Ridker PM, Danesh J, Youngman L, et al.: A prospective study of H. pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men. Ann Intern Med 135:184-188, 2001
15. Gallin JL, Kaye D, O'Leary WM: Serum lipid in infection. N Engl J Med 281:1081-1086, 1969
16. Alvarez C, Ramos A: Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem Res 32:142-145, 1986
17. Kerttula Y, Weber T: Serum lipids in pneumonia of different aetiology. Ann Clin Res 20:184-188, 1988
18. Grunfeld C, Gulli R, Moser AH, Gavin LA, Feingold KR: Effect of tumour necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J Lipid Res 30:579-585, 1989
19. Kaukoranta-Tolvanan SS, Teppo AM, Laitinen K, Saikku P, Linnavuori K, Leinonen M: Growth of C. pneumonia in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog 21:215-221, 1996
20. Lopes-Virella MF: Interactions between bacterial lipopolysaccharide and serum lipoproteins and their possible role in coronary heart disease. Eur Heart J 14:118-124, 1993